Glycogen synthase kinase-3β inactivation inhibits tumor necrosis factor-α production in microglia by modulating nuclear factor κB and MLK3/JNK signaling cascades
2010
GSK-3β Inactivation Reduces TNF-α Production in Microglia
publication
Evidence: moderate
Author Information
Author(s): Wang Mei-Jen, Huang Hsin-Yi, Chen Wu-Fu, Chang Hui-Fen, Kuo Jon-Son
Primary Institution: Buddhist Tzu Chi General Hospital
Hypothesis
How does GSK-3β inactivation affect TNF-α production in microglia?
Conclusion
Inactivation of GSK-3β may be a potential strategy to reduce inflammation in microglia.
Supporting Evidence
- GSK-3β inhibitors significantly reduced TNF-α production in response to LPS treatment.
- Loss of GSK-3β activity decreased TNF-α release in microglial cells.
- GSK-3β inactivation inhibited NF-κB transactivation activity.
- GSK-3β inhibition blocked JNK signaling, reducing TNF-α production.
Takeaway
When a specific protein called GSK-3β is turned off, it helps reduce a harmful substance called TNF-α that can cause brain inflammation.
Methodology
The study used LPS to induce inflammation in microglial cells and measured TNF-α production using ELISA, along with various signaling analyses.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website